Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

1331

Figures (1-3)

164

Tables (1-3)

184

Sum=1722

Publishing Process of This Article

Item

Count

Browse

Download

169

Sum=242

Apr 7, 2024 (publication date) through Aug 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Apr 7, 2024; 30(13): 1780-1790
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1780

Table 3 The summary of clinical trials investigating CA-4 in cancer treatment

Clinical trial number	Conditions	Trial stage	Enrollment	Study period
NCT01570790	Age-related macular degeneration	Phase I/II	8	2003-2005
NCT01423149	Myopia	Phase II	23	2005-2007
NCT00060242	Head and neck cancer	Phase II	26	2003-2008
NCT00113438	Cancer (non-specified)	Phase II	23	2005-2007
NCT00960557	Neoplasm metastasis	Phase I	16	2009-2010
NCT00077103	Head and neck cancer	Phase I/II	4	2003-2007 (terminated)
NCT00003768	Adult solid tumor (unspecified)	Phase I	25	1998-2001
NCT00507429	Anaplastic thyroid cancer	Phase II/III	80	2007-2011 (terminated)
NCT01023295	Polypoidal choroidal vasculopathy	Phase II	20	2009-2010
NCT00395434	Tumors (unspecified)	Phase I	20	2006-2007
NCT02576301	Acute myelogenous leukemia/myelodysplastic syndromes	Phase I/II	105	2015-2020 (status unknown)
NCT00003698	Adult solid tumor (unspecified)	Phase I	35	1998-2003
NCT01085656	Acute myelogenous leukemia/myelodysplastic syndromes	Phase I	18	2011-2016 (terminated)
NCT02279602	Neuroendocrine tumors	Phase II	7	2014-2016
NCT00699517	Sarcoma	Phase III	355	2008-2013
NCT02132468	Neuroendocrine tumors	Phase II	18	2014-2016
NCT01701349	Anaplastic thyroid cancer	Phase III	0	2015-2017 (withdrawn)
NCT00653939	Non-small cell lung cancer	Phase II	63	2008-2011
NCT02641639	Platinum-resistant ovarian cancer	Phase II/III	91	2016-2017 (terminated)
NCT01240590	Anaplastic thyroid cancer	Phase I/II	27	2011-2016

Citation: Kita K, Burdowski A. Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management. World J Gastroenterol 2024; 30(13): 1780-1790
URL: https://www.wjgnet.com/1007-9327/full/v30/i13/1780.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i13.1780